HOSHIDA LAB
  • HOME
  • MEMBERS
  • PUBLICATIONS
  • CONTACT
  • POSITIONS
Picture
Molecular signature for clinical outcome prediction.
We use genomic profiling to identify molecular signatures to predict clinical outcome of liver diseases.


Picture
Molecular classification of liver cancer to guide personalized treatment.
We use molecular classification of liver cancer to predict response to molecular targeted drugs.

Picture
Nanotechnology-based drug delivery for treatment of liver cirrhosis and cancer.
We develop nanoparticles for more effective and less toxic treatment of liver diseases.

Internal lab page
2023 Liver Tumor Translational Research Program
Harold C. Simmons Comprehensive Cancer Center
Division of Digestive and Liver Diseases, Department of Internal Medicine
University of Texas Southwestern Medical Center
  • HOME
  • MEMBERS
  • PUBLICATIONS
  • CONTACT
  • POSITIONS